Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) was $20.32 for the day, down -0.59% from the previous closing price of $20.44. In other words, the price has decreased by -$0.59 from its previous closing price. On the day, 0.5 million shares were traded. SNDX stock price reached its highest trading level at $20.88 during the session, while it also had its lowest trading level at $20.2101.
Ratios:
Our analysis of SNDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 10.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On January 31, 2024, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform and also lowered its target price recommendation from $36 to $23.
On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.Mizuho initiated its Buy rating on December 22, 2023, with a $45 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 14 ’24 when Goldan Keith A. bought 1,250 shares for $20.03 per share. The transaction valued at 25,037 led to the insider holds 52,623 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1729158784 and an Enterprise Value of 1298020992. For the stock, the TTM Price-to-Sale (P/S) ratio is 494.07 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 370.863 whereas that against EBITDA is -4.507.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is -4.39%, while the 200-Day Moving Average is calculated to be -1.94%.
Shares Statistics:
SNDX traded an average of 1.10M shares per day over the past three months and 812110 shares per day over the past ten days. A total of 84.83M shares are outstanding, with a floating share count of 79.38M. Insiders hold about 6.72% of the company’s shares, while institutions hold 97.13% stake in the company. Shares short for SNDX as of 1722384000 were 8588022 with a Short Ratio of 7.84, compared to 1719532800 on 8343432. Therefore, it implies a Short% of Shares Outstanding of 8588022 and a Short% of Float of 10.18.
